Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
(Angiotensin II receptor blockers)
30,853 results
  • Contemporary Management of Heart Failure in the Elderly. [Review]
  • DADrugs Aging 2018 Dec 11
  • Osmanska J, Jhund PS
  • The foundation of the treatment of heart failure with reduced ejection fraction is a number of pharmacotherapies shown to reduce morbidity and mortality in large randomised multinational clinical tri...
  • Bioactive Signaling in Next-Generation Pharmacotherapies for Heart Failure: A Review. [Journal Article]
  • JCJAMA Cardiol 2018 Nov 28
  • Oatmen KE, Zile MR, … Spinale FG
  • CONCLUSIONS: This review identified that activation rather than inhibition of specific receptor pathways provided favorable cardiovascular effects that cannot be achieved by renin-angiotensin system inhibition alone. Thus, an entirely new avenue of translational and clinical research lies ahead in which HF pharmacotherapies will move beyond receptor antagonist strategies.
New Search Next